Caption Management’s Bio-Techne TECH Stock Holding History

Caption Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Buy	200,000 +139,800	+232%	+$8.39M	0.06%	321
2025 Q4	$3.54M	Buy	+60,200	New	+$3.66M	0.02%	620
2024 Q4	–	Sell	-15,000	Closed	-$1.2M	–	1820
2024 Q3	$1.2M	Buy	+15,000	New	+$1.13M	0.02%	724
2023 Q4	–	Sell	-53,200	Closed	-$3.62M	–	1667
2023 Q3	$3.62M	Buy	+53,200	New	+$4.2M	0.06%	411

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caption Management's TECH Position: Q1 2026 in Review

Caption Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 100,000 shares — an estimated $6M sold.

Caption Management first reported a position in TECH in Q3 2025 and held it in 2 quarters. The position peaked at $5.88M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

Caption Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
Caption Management sold 100,000 Bio-Techne shares in Q1 2026, an estimated $6M.
Caption Management first reported a position in Bio-Techne in Q3 2025 and held it in 2 quarters.
Caption Management's Bio-Techne position peaked at $5.88M in Q4 2025.
582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.